Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology

Blood. 1996 Jul 1;88(1):3-40.

Authors

J N George¹, S H Woolf, G E Raskob, J S Wasser, L M Aledort, P J Ballem, V S Blanchette, J B Bussel, D B Cines, J G Kelton, A E Lichtin, R McMillan, J A Okerbloom, D H Regan, I Warrier

Affiliation

¹ Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, 73190, USA.

PMID: 8704187

No abstract available

Publication types

Guideline
Practice Guideline
Research Support, Non-U.S. Gov't
Review

MeSH terms

Adult
Autoimmune Diseases / therapy*
Bone Marrow Examination
Child
Clinical Trials as Topic
Combined Modality Therapy
Emergencies
Female
Glucocorticoids / therapeutic use
Hemorrhage / etiology
Hemorrhage / prevention & control
Hospitalization
Humans
Immunity, Maternally-Acquired
Immunoglobulins, Intravenous / therapeutic use
Immunosuppressive Agents / therapeutic use
Infant, Newborn
Male
Platelet Count
Pregnancy
Pregnancy Complications, Hematologic / diagnosis
Pregnancy Complications, Hematologic / therapy
Purpura, Thrombocytopenic, Idiopathic / complications
Purpura, Thrombocytopenic, Idiopathic / congenital
Purpura, Thrombocytopenic, Idiopathic / diagnosis
Purpura, Thrombocytopenic, Idiopathic / therapy*
Rho(D) Immune Globulin / therapeutic use
Splenectomy
Treatment Outcome

Substances

Glucocorticoids
Immunoglobulins, Intravenous
Immunosuppressive Agents
Rho(D) Immune Globulin